RECON BIOINFORMATICS ENGINE Trademark

Trademark Overview


On Tuesday, December 4, 2018, a trademark application was filed for RECON BIOINFORMATICS ENGINE with the United States Patent and Trademark Office. The USPTO has given the RECON BIOINFORMATICS ENGINE trademark a serial number of 88216665. The federal status of this trademark filing is REGISTERED as of Tuesday, September 24, 2019. This trademark is owned by Neon Therapeutics, Inc.. The RECON BIOINFORMATICS ENGINE trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical and pharmaceutical consultation; providing information relating to therapeutic properties of pharmaceuticals

Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; and consulting services for others in the field of design, planning, and implementation of clinical trials
recon bioinformatics engine

General Information


Serial Number88216665
Word MarkRECON BIOINFORMATICS ENGINE
Filing DateTuesday, December 4, 2018
Status700 - REGISTERED
Status DateTuesday, September 24, 2019
Registration Number5866191
Registration DateTuesday, September 24, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements


Description of MarkThe mark consists of the word "RECON" with a double helix design incorporated in the letter E stacked on top of the words "BIOINFORMATICS" and "ENGINE" in the lower right corner.
Amendment to a Registration/Renewal CertificateIssue New Certificate to: BioNTech US Inc. (Delaware corporation) 40 Erie Street, Suite 110, Cambridge MA 02139.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical and pharmaceutical consultation; providing information relating to therapeutic properties of pharmaceuticals
NOT AVAILABLE"BIOINFORMATICS ENGINE"
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; and consulting services for others in the field of design, planning, and implementation of clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 21, 2018
Primary Code042
First Use Anywhere DateFriday, March 2, 2018
First Use In Commerce DateFriday, March 2, 2018

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 21, 2018
Primary Code044
First Use Anywhere DateFriday, March 2, 2018
First Use In Commerce DateFriday, March 2, 2018

Trademark Owner History


Party NameBioNTech US Inc.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameNeon Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameNeon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameNeon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Monday, March 4, 2019ASSIGNED TO EXAMINER
Friday, December 7, 2018NEW APPLICATION ENTERED
Friday, December 21, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 22, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 5, 2019NON-FINAL ACTION WRITTEN
Tuesday, March 5, 2019NON-FINAL ACTION E-MAILED
Tuesday, March 5, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 17, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 3, 2019ASSIGNED TO LIE
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 24, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, January 6, 2022TEAS SECTION 7 REQUEST RECEIVED
Friday, June 3, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 3, 2022NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
Tuesday, September 24, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED